Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03018405
Title A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications (THINK)
Acronym THINK
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Celyad Oncology SA
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | BEL

Facility Status City State Zip Country Details
RECRUITING Tampa Florida 33612 United States Details
RECRUITING Buffalo New York 14263 United States Details
RECRUITING Brussels 1200 Belgium Details
RECRUITING Brussels Belgium Details
RECRUITING Ghent Belgium Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field